Buy. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Copyright © 2021. Baudax Bio, Inc. (BXRX) estimates and forecasts Oppenheimer Holdings Inc. has the highest price target set, predicting BXRX will reach $14.00 in the next twelve months. Investment News. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. The high price target for BXRX is $14.00 and the low price target for BXRX is $13.00. Baudax Bio Inc has risen 51.02% over the past month, closing at $1.07 on December 23. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Oppenheimer Holdings Inc. has the highest price target set, predicting BXRX will reach $14.00 in the next twelve months. Oppenheimer Holdings Inc. has the highest price target set, predicting BXRX will reach $14.00 in the next twelve months. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. BXRX Stock Summary. appreciate its future potential. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Just click the link View real-time stock prices and stock quotes for a full financial overview. During this period of time, the stock fell as low as $1.00 and as high as $1.52. The average price target is $4.67 with a high forecast of $6.00 and a low forecast of $3.00. Average Price Target. Equity Analysis OCUL stock: Ocular Therapeutix (OCUL) Is Better Than You Think. The dark blue line represents the company's actual price. Average Share Price and Price Target by Month. Sign Up to See 11/09 07:08. Fundamental company data provided by Zacks Investment Research. Baudax Bio Inc. [BXRX] Price Analysis: Next Bullish Target is $15.00. Analysts have been projecting $3 as a low price target for the stock while placing it at a high target of $6. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. • Infrastructure Sector in 2021: The Complete Investors Guide. Facebook. NASDAQ 0.00%. Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. WhatsApp . Strong Sell . Identify stocks that meet your criteria using seven unique stock screeners. View detailed financial information, real-time news, videos, quotes and analysis on Baudax Bio Inc (NASDAQ:BXRX). Ocular Therapeutix (OCUL) has performed well over the past year. BXRX | Complete Baudax Bio Inc. stock news by MarketWatch. $14.00 +879.02%. View which stocks are hot on social media with MarketBeat's trending stocks report. The current price of Baudax Bio is the price at which Baudax Bio is currently trading. WhatsApp. DOW 30,924.14. Find market predictions, BXRX financials and market news. The lighter blue line … JMP Securities has the lowest price target set, forecasting a price … Get the latest Price and Consensus Chart for Baudax Bio, Inc. from Zacks Investment Research Learn about financial terms, types of investments, trading strategies and more. Sell. Baudax Bio to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Please log in to your account or sign up in order to add this asset to your watchlist. Pinterest. Their average twelve-month price target is $13.67, suggesting a possible upside of 951.3%. Avg Forecast. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). NasdaqCM:BXRX Earnings and Revenue Growth November 10th 2020 The consensus price target fell 6.9% to US$9.00, with the analysts clearly less … 0 analysts 0%. Baudax Bio, Inc. 1.21 0.01 (0.82%) Watch. BXRX: Baudax Bio, Inc. - Price and Consensus Chart. On the other hand, Baudax Bio's target price is what analysts think … We have 9 different ratings for every stock to help you Login BXRX 1.21 0.01 (0.82%) Post-Market 0.00 (0.00%) … See the POWR Ratings now! Buy. Learn everything you need to know about successful options trading with this three-part video course. Alaa1990. Mark Image. BXRX stock forecasts by analyst. Do Not Sell My Information. US stock market today: stock quotes, stock screener, stock charts, insiders trading, market news, portfolio tracking, and cryptocurrencies. Find the latest Baudax Bio, Inc. (BXRX) stock quote, history, news and other vital information to help you with your stock trading and investing. Their average twelve-month price target is $13.50, predicting that the stock has a possible upside of 946.51%. BXRX, 240. Latest Analyst Research & Price Targets for Baudax Bio Inc (BXRX-Q). Analyst price target for BXRXBased on 1 analysts offering 12 month price targets for Baudax Bio Inc. Min Forecast. By slimmest of margins, Senate takes up $1.9T relief bill. In depth view into Baudax Bio Price Target Upside (Daily) including historical data from 2019, charts, stats and industry comps. $14.00 +879.02%. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Kiel Thompson - April 6, 2020. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. 3. All rights reserved. STYLIZED WORDS BAUDAX BIO WITH A DESIGN OVER THE LETTER X IN BAUDAX . Max Forecast. Good Luck Thanks 3. Benzinga Newsdesk, Benzinga Staff Writer {{following ? See You can opt out at any time. Log In. Get short term trading ideas from the MarketBeat Idea Engine. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Hold. Sign Up. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. The average price target represents a 282.79% increase from the last price of $1.22. All 'A' Rated Buy Stocks, • 3 Small-Cap Value Stocks for an Improving Economy. Baudax Bio Inc's NA is greater than just about none of of all US stocks. ... First Target 1.47 2nd Target 2.43 and then 3.23. Learn more. Analyst Price Target on BXRX. The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BXRX as an investment opportunity. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. BXRX's went public 1.31 years ago, making it older than merely 0.8% of listed US stocks we're tracking. 11/02 07:05. Rooms Shows Rankings Earnings Calendar Shop. Based on analysts offering 12 month price targets for BXRX in the last 3 months. "Following" : "Follow"}} May 11, 2020 7:40am 144 Comments. By Misty Lee. Baudax Bio Inc's average analyst price target is greater than 8.28% of all US stocks. 3 Overdone Selloffs Offering a Second Chance. 2019-10-01 "STYLIZED WORDS BAUDAX BIO WITH A DESIGN OVER THE LETTER X IN BAUDAX" 88637939. Find real-time BXRX - Baudax Bio Inc stock quotes, company profile, news and forecasts from CNN Business. Annabelle Farmer-February 18, 2021 0. Oppenheimer Holdings Inc. has the highest price target set, predicting BXRX will reach $14.00 in the next twelve months. I lost $80,000. BXRX's price/sales ratio is 170.02; that's higher than the P/S ratio of 97.49% of US stocks. Find real-time BXRX - Baudax Bio Inc stock quotes, company profile, news and forecasts from CNN Business. Figure 9: BXRX Revenue Estimates (Source: Seeking Alpha) This would be a forward price-to-sales of 0.77x, which means that the company would rake in more revenue than its current market cap. In the Healthcare industry, OPGN, PROG and AKU are the three stocks most similar to Baudax Bio Inc regarding the price target and analyst recommendation information presented here. DOW 0.00%. Most … 0 analysts 0%. Baudax Bio Inc Stock Forecast NASDAQ:BXRX Price Target and Analyst Ratings. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! The shares are currently trading for $49.25 and their $74 average price target implies … See what's happening in the market right now with MarketBeat's real-time news feed. Want to see which stocks are moving? Trending now. Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. The chart below shows how a company's share price and consensus price target have changed over time. Cancel. The Baudax Bio Inc stock price gained 2.09% on the last trading day (Friday, 5th Mar 2021), rising from $1.20 to $1.22.During the day the stock fluctuated 16.19% from a day low at $1.05 to a day high of $1.22. Their average twelve-month price target is $13.67, suggesting a possible upside of 754.2%. JMP Securities slashes price target on Baudax Bio Inc. [BXRX] – find out why. Twitter. NasdaqCM:BXRX Earnings and Revenue Growth November 10th 2020. 0. TheTradingTraveller. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. To see all exchange delays and terms of use, please see disclaimer. The company has an average price target of $9.67. Baudax Bio Inc. analyst ratings, historical stock prices, earnings estimates & actuals. The last trading period has seen Baudax Bio Inc. (BXRX) move -84.24% and 25.77% from the stock’s 52-week high and 52-week low prices respectively. In that case, then, we find that the current price level is +344.44% off the targeted high while a plunge would see the stock lose 122.22% from current levels. Long. S&P 500 3,768.47. Baudax Bio Inc (BXRX) Price Targets From Analysts. You can unlock it all now. above. The share price of Baudax Bio Inc. [NASDAQ: BXRX] inclined by $2.20, presently trading at $2.48. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. BXRX: currency: USD Stock Common: BAUDAX BIO INC: BXRX: Latest USPTO Trademark Filings . Volatile ride for Baudax Bio Inc stock price on Friday moving between $1.05 and $1.22 (Updated on March 05, 2021) Sell candidate since 2021-02-25 Loss -12.86% PDF . Their average twelve-month price target is $13.67, suggesting a possible upside of 951.3%. © American Consumer News, LLC dba MarketBeat® 2010-2021. View our full suite of financial calendars and market data tables, all for free. BXRX: Get the latest Baudax Bio stock price and detailed information including BXRX news, historical charts and realtime prices. -- Earnings Flash (BXRX) BAUDAX BIO Posts Q3 Revenue $68,000, vs. Street Est of $1M. Ratings...FREE! BXRX, 1D. Baudax Bio Target Price Projection Baudax Bio's current and average target prices are 1.35 and 7.33, respectively. Strong Buy. SA Breaking News. US stock market today: stock quotes, stock screener, stock charts, insiders trading, market news, portfolio tracking, and cryptocurrencies. Collection of curated. To see all exchange delays and terms of use please see disclaimer. With a year-over-year growth in debt of 1,164.94%, Baudax Bio Inc's debt growth rate surpasses 98.56% of about US stocks. Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. 1 analysts 100%. Baudax bio market goal + important levels. The extremes of the forecast give a target low and a target high price of $7 and $11 respectively. Must read. The most common way Baudax Bio analysts use to provide recommendation to the public is financial statements analysis. BXRX updated stock price target summary. Twitter. Detailed list of analyst forecasts. View BXRX's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. Based on 10 analysts offering 12 month price targets for BioCryst in the last 3 months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Just enter your email address below. View live BAUDAX BIO INC chart to track its stock's price action. The daily trading volume for Baudax Bio Inc. (NASDAQ:BXRX) over the last session is 3.47 million shares. Their average twelve-month price target is $13.67, suggesting a possible upside of 754.2%. Should I buy or sell BXRX stock? It follows that stock’s current price would jump +361.54% in reaching the projected high whereas dropping to the targeted low would mean a loss of 130.77% for stock’s current value.